Market Indices


Latest News

Key Points
- Rosen Law Firm reminds Atara Biotherapeutics, Inc. investors of...

May 1, 2026   ATRA 2.73%

from Jefferies issued a price target of $3.28 for

May 1, 2026   ESPR 55.50%

Following are the Top 5 companies based on their one-day percentage...

May 1, 2026   WOOD 0.40%

from Piper Sandler issued a price target of $3.16 for...

May 1, 2026   ESPR 55.50%

Jefferies analyst issues HOLD recommendation for ESPR on May 1,...

May 1, 2026   ESPR 55.50%


Price Targets

from Jefferies issued a price target of $3.28 for ESPR on 2026-05-01 19:20:08.The adjusted price target was set to $3.28.At the time of the announcement, ESPR was...

May 1, 2026   ESPR 55.50%

from Piper Sandler issued a price target of $3.16 for ESPR on 2026-05-01 18:01:37.The adjusted price target was set to $3.16.At the time of the announcement, ESPR...

May 1, 2026   ESPR 55.50%

from Cantor Fitzgerald issued a price target of $3.16 for ESPR on 2026-05-01 12:44:57.The adjusted price target was set to $3.16.At the time of the announcement, ESPR...

May 1, 2026   ESPR 55.50%

from Industrial Alliance Securities issued a price target of $2.00 for OPAD on 2026-05-01 11:54:09.The adjusted price target was set to $2.00.At the time of the announcement,

May 1, 2026   OPAD -15.61%

Brian Kinstlinger from Industrial Alliance Securities issued a price target of $2.75 for SRFM on 2026-05-01 11:06:23.The adjusted price target was set to $2.75.At the time of the announcement,...

May 1, 2026   SRFM 0.00%



Market Movers

Top Gainers (%)
CUE
Cue Biopharma, Inc.
30.42
106.38%
ESPR
Esperion Therapeutics, In
3.11
55.50%
UONE
Urban One, Inc.
7.31
39.24%
DRCT
Direct Digital Holdings,
3.95
32.99%
SST
System1, Inc.
3.94
21.60%
AXTI
AXT, Inc.
96.00
21.18%
ETON
Eton Pharmaceuticals, Inc
28.90
19.82%
ZTEK
Zentek Ltd.
0.51
19.31%

Annual/Quarterly Reports Summary

In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...

November 6, 2024   AIP -0.03%

In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...

November 6, 2024   EOSEW -34.96%

In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...

November 6, 2024   EOSE -3.73%

In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...

November 5, 2024   STOK 1.10%

In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...

November 5, 2024   BSVN 1.28%